{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:09:20Z","timestamp":1792786160382,"version":"4.5.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"name":"National Cancer Institute","award":["UM1CA221940"],"award-info":[{"award-number":["UM1CA221940"]}]},{"name":"American Cancer Society","award":["CRP-22-080-01-CTPS"],"award-info":[{"award-number":["CRP-22-080-01-CTPS"]}],"id":[{"id":"https:\/\/ror.org\/02e463172","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To quantify the association between time to colposcopy and risk of subsequent cervical cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>A longitudinal analysis of patients aged 21\u201379 years with an abnormal cervical cancer test result from health care systems in Texas, Massachusetts, and Washington was performed. The outcome was a cervical cancer diagnosis 12 months or more after the abnormal result. The primary analysis compared receipt of colposcopy within 3 months (91 days or less) with receipt of colposcopy at 3\u201312 months (92\u2013365 days) and no colposcopy within 12 months of the abnormal test result; post hoc analyses compared colposcopy within 12 months (365 days or less) with no colposcopy within 12 months. Associations were assessed with multivariable Cox proportional hazards regression controlling for age, risk status, result severity, and health care system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Of 17,541 patients, 53.3% of patients received colposcopy within 3 months, 22.2% received colposcopy in 3\u201312 months, and 24.6% had no colposcopy within 12 months. One hundred forty-seven patients were diagnosed with cervical cancer within 12 months and removed from subsequent analyses. Sixty-five patients (0.4%) were diagnosed with cervical cancer more than 1 year (366 days or more) after the abnormal Pap or human papillomavirus test result. The risk of cervical cancer detection more than 1 year after the abnormal test result was not different in patients who received colposcopy within 3\u201312 months (hazard ratio [HR] 1.07, 95% CI 0.54\u20132.12) and higher among patients with no colposcopy within 12 months (HR 2.34, 95% CI 1.33\u20134.14) compared with patients who had colposcopy within 3 months. Post hoc analyses showed that the risk of cervical cancer diagnosis was 2.29-fold higher among those without colposcopy within 12 months compared with those who received colposcopy within 12 months (95% CI 1.37\u20133.83); among patients with high-grade cytology results, the risk of cervical cancer detection among those without colposcopy within 12 months was 3.12-fold higher compared with those who received colposcopy within 12 months (95% CI 1.47\u20136.70).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>There was no difference in cervical cancer risk at more than 1 year between patients who received colposcopy within 3 months compared with those who received colposcopy within 3\u201312 months of an abnormal result. Patients who did not receive colposcopy within 12 months of an abnormal result had a higher risk of subsequent cervical cancer compared with those who received a colposcopy within 12 months.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005313","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T19:31:51Z","timestamp":1692732711000},"page":"1125-1134","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Timing of Colposcopy and Risk of Cervical Cancer"],"prefix":"10.1097","volume":"142","author":[{"given":"Stephanie","family":"Alimena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn M.","family":"Lykken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin A.","family":"Tiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Chubak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna","family":"Kamineni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah C.","family":"Kobrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,8,21]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2105\/AJPH.85.6.791","article-title":"The screening histories of women with invasive cervical cancer, Connecticut","volume":"85","author":"Janerich","year":"1995","journal-title":"Am J Public Health"},{"key":"R2-20260916","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1002\/cam4.5226","article-title":"Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings","volume":"12","author":"Chao","year":"2022","journal-title":"Cancer Med"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/LGT.0b013e3181f515a2","article-title":"Invasive cervical cancer and screening: what are the rates of unscreened and underscreened women in the modern era?","volume":"15","author":"Subramaniam","year":"2011","journal-title":"J Lower Genital Tract Dis"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/LGT.0000000000000338","article-title":"ASCCP colposcopy standards: role of colposcopy, benefits, potential harms, and terminology for colposcopic practice","volume":"21","author":"Khan","year":"2017","journal-title":"J Low Genit Tract Dis"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1309\/AJCPTGD94EVRSJCG","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"137","author":"Saslow","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"R6-20260916","first-page":"199","article-title":"Timely follow-up of positive cancer screening results: a systematic review and recommendations from the PROSPR Consortium","volume":"68","author":"Doubeni","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1136\/ijgc-2020-001617","article-title":"European Federation for Colposcopy (EFC) and European Society of Gynaecological Oncology (ESGO) joint considerations about human papillomavirus (HPV) vaccination, screening programs, colposcopy, and surgery during and after the COVID-19 pandemic","volume":"30","author":"Ciavattini","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"R8-20260916","first-page":"1","article-title":"Evaluation of different guidelines for cervical cancer screening and management of abnormal cervical cytology","volume":"5","author":"Ismael","year":"2020","journal-title":"Ann Cytol Pathol"},{"key":"R9-20260916","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/cncr.28821","article-title":"Using data to effectively manage a national screening program","volume":"120","author":"Yancy","year":"2014","journal-title":"Cancer"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"106569","DOI":"10.1016\/j.ypmed.2021.106569","article-title":"Prioritizing cervical cancer screening services during the COVID-19 pandemic: response of an academic medical center and a public safety net hospital in California","volume":"151","author":"Sawaya","year":"2021","journal-title":"Prev Med"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1158\/1055-9965.EPI-17-0378","article-title":"Effect of time to diagnostic testing for breast, cervical, and colorectal cancer screening abnormalities on screening efficacy: a modeling study","volume":"27","author":"Rutter","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R12-20260916","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ajog.2020.06.006","article-title":"Special ambulatory gynecologic considerations in the era of coronavirus disease 2019 (COVID-19) and implications for future practice","volume":"223","author":"Cohen","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1158\/1055-9965.EPI-22-0100","article-title":"Evaluating and improving cancer screening process quality in a multilevel context: the PROSPR II Consortium design and research agenda","volume":"31","author":"Beaber","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"107307","DOI":"10.1016\/j.ypmed.2022.107307","article-title":"Factors associated with timely colposcopy following an abnormal cervical cancer test result","volume":"164","author":"Feldman","year":"2022","journal-title":"Prev Med"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/ijc.31940","article-title":"Cervical cancer screening research in the PROSPR I Consortium: rationale, methods and baseline findings from a US cohort","volume":"144","author":"Kamineni","year":"2019","journal-title":"Int J Cancer"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ajog.2007.07.047","article-title":"2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"R18-20260916","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J Lower Genital Tract Dis"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCOUTCOMES.110.957951","article-title":"Landmark analysis at the 25-year landmark point","volume":"4","author":"Dafni","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R20-20260916","first-page":"703","article-title":"Socioeconomic status and breast cancer incidence in California for different race\/ethnic groups","volume":"12","author":"Yost","year":"2001","journal-title":"Cancer Causes Control"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"106640","DOI":"10.1016\/j.ypmed.2021.106640","article-title":"The trajectory of racial\/ethnic disparities in the use of cancer screening before and during the COVID-19 pandemic: a large U.S. academic center analysis","volume":"151","author":"Marcondes","year":"2021","journal-title":"Prev Med"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:05:49Z","timestamp":1789556749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,21]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005313","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,21]]},"assertion":[{"value":"2023-04-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}